Drug Safety Is Influenced More by Business Interests Rather Than Public Health
| dc.contributor.author | Lexchin, Joel | |
| dc.date.accessioned | 2015-05-21T17:50:39Z | |
| dc.date.available | 2015-05-21T17:50:39Z | |
| dc.date.issued | 2011 | |
| dc.description | en_US | |
| dc.description.abstract | The safety of pharmaceutical drugs in Canada is a concern. While Health Canada is given the power to measure safety and approve drugs, the process has its limits. There is a growing trend towards practicing “risk management” rather than the “precautionary principle” when drugs are approved. There is also a greater priority put on meeting the interest of drug companies compared to the potential harm to public health. “Progressive licensing” would allow for drugs to be assessed for safety even after it’s approved. | en_US |
| dc.description.sponsorship | York's Knowledge Mobilization Unit provides services and funding for faculty, graduate students, and community organizations seeking to maximize the impact of academic research and expertise on public policy, social programming, and professional practice. It is supported by SSHRC and CIHR grants, and by the Office of the Vice-President Research & Innovation. kmbunit@yorku.ca www.researchimpact.ca | en_US |
| dc.identifier | 00154 | |
| dc.identifier.citation | Lexchin, J. (2010). Drug safety and Health Canada. International Journal of Risk and Safety in Medicine, 22(1), 41-53. | en_US |
| dc.identifier.uri | http://hdl.handle.net/10315/29213 | |
| dc.relation | York University | en_US |
| dc.relation.uri | en_US | |
| dc.rights | Attribution-Noncommercial-No Derivative Works 2.5 Canada | en_US |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/2.5/ca/ | en_US |
| dc.subject | Health | en_US |
| dc.subject | Business | en_US |
| dc.subject | Law | en_US |
| dc.title | Drug Safety Is Influenced More by Business Interests Rather Than Public Health | en_US |
| dc.type | Research Summary | en_US |
Files
Original bundle
1 - 1 of 1